Harry Joshua Posen
YOU?
Author Swipe
View article: Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination Open
There is a limited supply of COVID-19 vaccines, with less than 20% of eligible populations in low-income countries having received one dose. Intradermal delivery of fractional dose vaccines is one way to improve global vaccine access, but …
View article: Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination Open
There is a limited supply of COVID-19 vaccines, with less than 20% of eligible populations in low-income countries having received one dose. Intradermal delivery of fractional dose vaccines is one way to improve global vaccine access, but …